The diagnosis and basic understanding ofmany genetic ocular disorders have been aided by the identification of the disease causing chromosomal loci. These chromosomal loci have been mapped using the candidate gene or the positional cloning approaches. This review will focus on genetic disorders that primarily affect ocular function with emphasis on the most recent advances in the chromosomal mapping of these disorders. In particular, we will concentrate on the genetic diseases affecting the posterior segment of the eye including the retina, choroid, and vitreous. The success of linkage analysis has relied heavily on previous clinical classifications and there are numerous reports of distinct ocular diseases mapping to specific chromosomal loci. However, there are also many examples in which a well defined disease maps to any of a number of chromosomal loci. This genetic phenomenon is known as non-allelic or locus heterogeneity and can be viewed as reflecting the eye's limited repertoire of responses to a variety of genetic lesions. Another emerging pattern is that of "gene sharing" in which different mutations within the same gene can cause clinically distinct ocular diseases. Mapping of mendelian genetic disorders has helped refine the clinical classifications and has led to examples of both "lumping" and "splitting".
Ocular tumours

RETINOBLASTOMA
Retinoblastoma, an embryonic neoplasm of the retina, is the most common primary intraocular malignancy in infants and children. The average annual incidence ofretinoblastoma in the US population younger than 10 years old is 10-9 per million.' The gene maps to chromosome 13q14, consists of 27 exons spanning 180 to 388 bp of genomic DNA, produces a 4-7 kb transcript, and encodes a nuclear phosphoprotein consisting of 928 amino acids. The complete gene sequence is available. The molecular basis of reduced penetrance has been investigated in eight different families."" '7 Two families with reduced penetrance have mutations in the promoter region of the retinoblastoma gene that decrease but do not eliminate the Rb gene product and three families have a mutation that produces a mutant protein with presumed diminished tumour suppressor activity. One of the families studied actually has "pseudo-low penetrance" owing to independently derived Rb mutations in distant relatives. 7 In another two families, no common intragenic haplotypes were identified in relatives with retinoblastoma and no mutations were identified in the Rb genes.'6 These two families could be other examples of "pseudolow penetrance" with relatives having independently derived Rb mutations.
Colour blindness PROTAN AND DEUTAN SERIES
The red and green visual pigment genes have been cloned, sequenced, and mapped.'820 Mutations in these genes are the molecular basis for X linked colour vision abnormalities.2'-23 Genes for the red and green opsins lie on the long arm ofthe X chromosome within Xq28. These genes are arranged in a tandem array with one copy of the red pigment gene at the 5' end and from one to five green pigment genes located downstream in a head to tail configuration presumably arising from unequal homologous recombination events. Only a single green pigment gene is expressed from this locus, probably the most proximal copy. 24 More than 95% of cases of red-green colour blindness arise from mutant genotypes owing to unequal intra-and intergenic re-combination events giving rise to deletions or hybrid genes within the tandem array of pigment genes.2' 25-28 These mutations are the genetic basis for protanopia (absence of red colour vision), protanomaly (anomalous red colour vision), deuteranopia (absence of green colour vision), and deuteranomaly (anomalous green colour vision). A missense mutation within the human green visual pigment gene is another cause of deuteranomaly.29 There is a direct correlation between anomalous red/green vision as detected by psychophysical experiments and the shifts in the in vitro absorption maxima of hybrid pigments produced from cloned cDNAs when compared to normal cone pigments. [30] [31] [32] In normal trichromats who display person to person variability in red colour matching, two common alleles of the red pigment gene have been identified and the respective shifts in their absorption maxima can account for the differences in psychophysical testing. 32 Forsius-Eriksson type ocular albinism or ocular albinism type 2 (OA2) was originally described in a family from the Aland Islands in the Sea of Bothnia. This form of ocular albinism is referred to as Aland Island eye disease (AIED). OA2 or AIED is inherited as an X linked recessive disorder. This form of ocular albinism has the clinical characteristics described for OA1. In addition, affected males with OA2 often have progressive axial myopia, astigmatism, defective dark adaptation, and protanomalous colour blindness. In contrast to OA1, the pigment containing cells in OA2 appear normal and there is no evidence of optic nerve fibre misrouting at the chiasm. Based on electrophysiological techniques, OA2 has been considered by some to be a form of congenital stationary night blindness with myopia (CSNB1).5664 The gene for OA2 was mapped by multilocus linkage analysis to the proximal region of Xp (Xp 1 .3),"" the same region implicated in typical X linked congenital stationary night blindness with myopia and a form of retinitis pigmentosa. The possibility exists that OA2, congenital stationary night blindness, and retinitis pigmentosa are allelic. There is a discrepancy between mapping of OA2 to Xpl 1.3 and the finding that a patient with the clinical characteristics of OA2 and Duchenne muscular dystrophy carries a deletion of Xp2 1.3-21.2.65 66 This finding would support the presence of an additional locus on the X chromosome for ocular albinism that closely resembles OA2.
A third form of ocular albinism (OA3) is inherited as an autosomal recessive disorder. This may be the genetic type found in most isolated cases of females with ocular albinism. OA3 is phenotypically similar to OA2 except that males and females are equally affected. Deletion analysis of one patient with OA3 has permitted a tentative chromosomal assignment to the ql3-ql5 region of chromosome 6.67
Retinitis pigmentosa
Retinitis pigmentosa (RP) is a set of genetic diseases that feature progressive photoreceptor degeneration. Tunnel vision caused by the early loss of peripheral photoreceptors is one hallmark of this disease. As the disease progresses, central vision is lost as well. On examination, middle aged patients with RP classically have fundus changes that include peripheral intraretinal pigmentation known as bone spicules, retinal vessel attenuation, and optic nerve head pallor. Diagnosis often depends upon full field electroretinographic testing, dark adaptation threshold testing, and evaluation of visual fields. The disease is genetically heterogeneous and can be inherited as an autosomal dominant, autosomal recessive, or X linked trait. Affected subjects without a family history of RP are designated as isolate or simplex cases. Most isolate cases are probably recessive cases although some may be X linked cases or new dominant mutations. Populations differ in the prevalence of each genetic type, but the recessive and isolate types usuallv account for the majority of cases.68 Autosomal recessive RP in association with hearing less is known as Usher syndrome and will be discussed separately. At least 11 chromosomal regions have been implicated as containing genes causing RP, and four of the genes have been identified. The numerical designation for each locus (for example, RP-1, RP-2, etc) used by McKusick in Mendelian inheritance in man (1 1th edition, 1994) and its online version (OMIM) has only categorical significance and does not correlate with disease severity, chronological order of gene identification, or population prevalence. 69 The first RP locus mapped was for an X linked form ofthe disease.70 Subsequent linkage and heterogeneity analyses support the existence ofat least two loci on the X chromosome that are associated with RP.7' These unidentified loci have been designated RP-2 and RP-3. RP-2 was localised within Xpl 1. ret- initis punctata albescens,"2 and fundus flavimaculatus.'09 An autosomal recessive form of fundus flavimaculatus with juvenile onset and severe progressive visual loss known as Stargardt disease has recently been mapped to the short arm of chromosome 1.149150 Autosomal dominant forms of this disease have been mapped to chromosome 13q34'5' and to the long arm of chromosome 6 between loci D6S313 (6ql3-ql6.2) and D6S252 (6ql4-qi 6.2). '52 Linkage to the North Carolina macular dystrophy gene on chromosome 6 was excluded in this family with autosomal dominant Stargardt-like disease.
Chorioretinopathies CHOROIDEREMIA Choroideremia (CHM), an X linked recessive disorder, causes constriction of peripheral vision and reduction of night vision. There is progressive loss of central vision leading to blindness usually in the fourth to fifth decade of life owing to progressive degeneration of the retina, the retinal pigment epithelium, and the choroid. While heterozygous women are usually asymptomatic, they may have irregularly pigmented fundi and peripapillary chorioretinal atrophy. Rarely, they may also lose vision. The disease locus was mapped to band Xq21 by both linkage analysis of pedigrees and cytogenetic analysis ofpatients with detectable chromosomal translocations and deletions.153 154 Mutations in a gene encoded within this region, the CHM gene, have been identified in families with choroideremia. [153] [154] [155] [156] [157] [158] The predicted sequence of the putative CHM gene product was found to be homologous to a bovine protein that inhibits the exchange of GTP for bound GDP on Rab 3A, known as Rab3A-GDP dissociation inhibitor (Rab3A-GDI).'59-'6 Subsequently, the CHM gene was found to be homologous to component A of rat Rab geranylgeranyl transferase. ' 
Conclusion
The primary genetic disorders of the retina, choroid, and vitreous discussed in this review are summarised along with their MIM (Mendelian inheritance in man) number in the accompanying table and idiograms. If a locus has been identified as a cause for a disorder, the MIM number for that disease is assigned according to the identified disease gene. The phenomenon of locus or non-allelic heterogeneity can be appreciated in the table by the different MIM numbers and genes that are assigned to the same clinical disorder. The prevalence of "gene sharing" allelism between clinically distinct disorders is evident by the repeated reference to the same gene or MIM number for different diseases and the presence of grouped disorders adjacent to a chromosomal location in the idiograms. This summary shows a genetic complexity to the mapping ofocular disorders that could not have been appreciated by using clinical classification schemes alone.
Note added in proof Since this review was submitted, several noteworthy chromosomal loci associated with posterior segment ocular disorders have been published. A digenic form of retinitis pigmentosa was reported in three unrelated families. 220 In these families, affected subjects were double heterozygotes with mutations in the unlinked peripherin/RDS and ROMI genes. A heterozygous missense mutation in the rod cGMP phosphodiesterase P-subunit genes was reported to cosegregate with autosomal dominant stationary night blindness in one family.22' The Bardet-Biedl syndrome was mapped to a second locus on chromosome lq. 222 An autosomal dominant macular degeneration known as Sorsby's fundus dystrophy was mapped to chromosome 22q13-qter. 223 The locus for autosomal dominant cystoid macular dystrophy was mapped to chromosome 7p 15-p2 1.224
